Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
102,893,652
-
Share change
-
+4,014,183
-
Total reported value
-
$337,471,159
-
Put/Call ratio
-
71%
-
Price per share
-
$3.28
-
Number of holders
-
140
-
Value change
-
+$16,684,872
-
Number of buys
-
74
-
Number of sells
-
46
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q2 2020
As of 30 Jun 2020,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,893,652 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MSD Partners, L.P., MILLER VALUE PARTNERS, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, and JPMORGAN CHASE & CO.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.